The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer.
<h4>Purpose</h4>To examine the in vitro and in vivo efficacy of the dual PI3K/mTOR inhibitor NVP-BEZ235 in treatment of PIK3CA wild-type colorectal cancer (CRC).<h4>Experimental design</h4>PIK3CA mutant and wild-type human CRC cell lines were treated in vitro with NVP-BEZ235, and the resulting effec...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science (PLoS)
2011-01-01
|
| Sarja: | PLoS ONE |
| Linkit: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025132&type=printable |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
